Patents

Biogen Inc (NASDAQ: BIIB) shares were trading higher Wednesday following the issuing of a decision by the U.S. Patent and Trademark Office's Patent Trial and Appeal Board on a patent trial challenge by Mylan NV (NASDAQ: MYL) on '514 Tecfidera that was in Biogen's favor....

The International Business Machines Corporation (NYSE: IBM), or IBM, has received a patent for a so-called "self-aware token" that tracks its complete life cycle even during offline transactions. What Happened The United States Patent and Trademark Office awarded the patent to IBM on...

OneConnect Financial Technology Ltd, a subsidiary of China’s largest insurer Ping An Insurance (Group) Co of China Ltd (OTC: PNGAY), filed for an initial public offering with the U.S. Securities and Exchange Commission on Wednesday. What Happened The fintech company is aiming to...

Aclaris Therapeutics Inc (NASDAQ: ACRS) shares were seeing some upward momentum Tuesday on the back of the announcement of a patent win. What Happened The U.S. Patent and Trademark Office has granted the company a patent — No. 10,335,391 — covering the methods to treat facial...

Apple Inc. (NASDAQ: AAPL) was granted 2,160 patents throughout 2018, suggesting the company's era of innovation is far from "dead," according to Bank of America Merrill Lynch.  The Analyst Wamsi Mohan maintained a Buy rating on Apple with an unchanged $230 price target...

Vireo Health International (OTC: VREOF) said Thursday that the United States Patent and Trademark Office has issued a Notice of Allowance for its patent application for less-harmful tobacco products infused with cannabinoids. What Happened The patent is titled "Tobacco Products with...

Shares of Groupon Inc (NASDAQ: GRPN) gained more than 3 percent Monday after the mobile and online marketplace company reached a settlement in patent litigation with IBM (NYSE: IBM) and struck a new patent cross-license agreement with Big Blue.  What Happened Groupon was accused by...

Patent risk management services company RPX Corp (NASDAQ: RPXC) has long been rumored to be a takeover target. In March, the company was reportedly approached by private equity firms regarding a potential buyout. Recent M&A speculation surrounding the company led to comments on the rumor...

The U.S. Patent and Trademark Office ruled in favor of Eli Lilly and Co (NYSE: LLY) Thursday in an inter partes review of the ’209 patent for Alimta, a chemotherapy drug for lung cancer. “Based on the record before us, we conclude that petitioner has failed to demonstrate by a...

Cesca Therapeutics Inc (NASDAQ: KOOL) shares have moved out of a one-year trading range of $2.50–$4 Tuesday and are currently at their highest level in over a year. The catalyst being an announcement from the company that the U.S. Patent and Trademark Office issuing a notice of allowance...

Digital Ally, Inc. (NASDAQ: DGLY) shares popped as much as 79 percent in Friday’s pre-market session after the company reported “significant victory” in its legal battle with Axon Enterprise Inc (NASDAQ: AAXN). The U.S. Patent and Trademark Office (PTO) denied Axon’s...

Litigations more often trigger strong stock moves, and this was evident in the rally by the shares of ParkerVision, Inc. (NASDAQ: PRKR) last Wednesday. ParkerVision Goes 4 Up Over Qualcomm ParkerVision announced on Wedneday that the Patent Trial and Appeal Board's latest decisions with respect...